483 Ningxia Qiyuan Pharmaceutical Jun 2019

483 Ningxia Qiyuan Pharmaceutical Jun 2019

Marijo Kambere FDA$119.00 - Available Now

FDA investigators audited the Ningxia Qiyuan Pharmaceutical - Yinchuan, China facility and issued inspectional observations (via FDA 483) on 28 Jun 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Jun 2019
  • Location: Yinchuan, China
  • FEI: 3004341367
Add To Cart